Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc.verified

TENX

Price:

$4.47

Market Cap:

$15.24M

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax The...[Read more]

Industry

Biotechnology

IPO Date

1994-04-04

Stock Exchange

NASDAQ

Ticker

TENX

The Enterprise Value as of November 2024 (TTM) for Tenax Therapeutics, Inc. (TENX) is 6.13M

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.13M. This represents a change of -241.96% compared to the average of -4319868.46 of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical Enterprise Value (quarterly & annually)

How has TENX Enterprise Value performed in the past?

The mean historical Enterprise Value of Tenax Therapeutics, Inc. over the last ten years is 1.50B. The current 6.13M Enterprise Value has changed -59.03% with respect to the historical average. Over the past ten years (40 quarters), TENX's Enterprise Value was at its highest in in the April 2015 quarter at 7.69B. The Enterprise Value was at its lowest in in the December 2018 quarter at -10595881.00.

Quarterly (TTM)
Annual

Average

1.50B

Median

14.72M

Minimum

-10595881.00

Maximum

7.36B

Tenax Therapeutics, Inc. (TENX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 278.01%

Maximum Annual Enterprise Value = 7.36B

Minimum Annual Increase = -6650.77%

Minimum Annual Enterprise Value = -10595881.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-3842667.00-297.01%
20221.95M-87.89%
202116.11M20.79%
202013.33M-98.08%
2019694.11M-6650.77%
2018-10595881.00-186.67%
201712.22M-99.72%
20164.38B-40.57%
20157.36B194.15%
20152.50B278.01%

Tenax Therapeutics, Inc. (TENX) Average Enterprise Value

How has TENX Enterprise Value performed in the past?

The current Enterprise Value of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.74M

5-year avg

144.33M

10-year avg

1.50B

Tenax Therapeutics, Inc. (TENX) Enterprise Value vs. Peers

How is TENX’s Enterprise Value compared to its peers?

Tenax Therapeutics, Inc.’s Enterprise Value is greater than Allarity Therapeutics, Inc. (-15916163.00), greater than NeuroBo Pharmaceuticals, Inc. (-6292396.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Virax Biolabs Group Limited (5.49M), greater than Quoin Pharmaceuticals, Ltd. (3.24M), less than Blue Water Vaccines, Inc. (8.67M), greater than PaxMedica, Inc. Common Stock (959.26K), greater than Revelation Biosciences, Inc. (-8886223.00), greater than ZyVersa Therapeutics, Inc. (1.84M), greater than Sonnet BioTherapeutics Holdings, Inc. (-448232.00), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than Altamira Therapeutics Ltd. (1.17M), less than Windtree Therapeutics, Inc. (8.18M), greater than Dermata Therapeutics, Inc. (-3107527.00), less than Ensysce Biosciences, Inc. (8.03M), greater than Panbela Therapeutics, Inc. (5.93M), less than Baudax Bio, Inc. (15.86M), less than Aditxt, Inc. (12.23M), less than Unicycive Therapeutics, Inc. (50.32M),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tenax Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tenax Therapeutics, Inc. (TENX)?

What is the 3-year average Enterprise Value for Tenax Therapeutics, Inc. (TENX)?

What is the 5-year average Enterprise Value for Tenax Therapeutics, Inc. (TENX)?

How does the current Enterprise Value for Tenax Therapeutics, Inc. (TENX) compare to its historical average?